Advanced Skin Cancers Coverage from Every Angle
Editor:
Soo Park, MD
Advertisement
Advertisement

News

Novel Compound Targeting Skin Cancer–Associated HPV5 Identified for Antiviral Drug Development
ASCO 2025: Frequency and Types of Targetable Mutations in Cutaneous Skin Cancers
ASCO 2025: Primary Results From the RELATIVITY-098 Trial in Completely Resected Melanoma
AACR 2025: What Role Do Potentially Modifiable Risk Factors Play in the Burden of MCC?
AACR 2025: Socioeconomic Status Linked to Disparities in Merkel Cell Carcinoma Outcomes
AACR 2025: AI Models May Help Diagnose Nonmelanoma Skin Cancers in Resource-Limited Regions
Mohs Surgery vs Wide Local Excision in cSCC
Prognostic Factors Seem to Favor Women in Global Study of Patients With Cutaneous Melanoma
Survivn Overexpression Tied to BCC Clone Size
Efficacy of Antibody Clones in Diagnosing Merkel Cell Carcinoma
Molecular Profile of Japanese Patients With Advanced Melanoma
Can Macrophage Activity Predict Immunotherapy Response in Patients With Melanoma?
Can Response to PD-L1 Inhibitors Influence Treatment Choices in Merkel Cell Carcinoma?
Antithrombotic Therapy Concomitant With Immunotherapy in Advanced Melanoma
Neoadjuvant T-VEC: An Option for Cutaneous Basal Cell Carcinoma?
Subcutaneous Injection of Nivolumab and Hyaluronidase-nvhy Approved by the FDA
Evaluating Mortality Risk Based on Breslow Thickness in Patients With Melanoma
Merkel Cell Carcinoma and Melanoma: Trends and Survival in the United States
Priority Review Granted by FDA for RP1 Plus Nivolumab in Advanced Melanoma
C-POST Trial: Cemiplimab-rwlc After Surgery for High-Risk Squamous Cell Skin Cancer
Copyright © 2025 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.